Posts by cstephenson@legacymedsearch.com
World’s First Long-Term Implantable Glucose Monitoring Device Now FDA Approved
GERMANTOWN, Md., June 21, 2018 — Senseonics Holdings, Inc. (NYSE American: SENS) today announced the U.S. Food and Drug Administration has approved its Pre-market Approval (PMA) application to market the company’s Eversense® Continuous Glucose Monitoring (CGM) System to people with diabetes in the United States. The system is the first and only CGM system to feature…
Read MoreMedtronic Receives Expanded Indication for Kyphon HV-R Bone Cement
Medtronic seems to be on a roll when it comes to innovation. The Dublin-based company has received the greenlight from FDA for an expanded indication of the Kyphon HV-R Bone Cement. Under the new indication, Medtronic can market Kyphon for the fixation of pathological fractures of the sacral vertebral body using sacral vertebroplasty or sacroplasty.…
Read MoreGE Booted From the Dow After More Than 100 Years
For the first time in 110 years, General Electric will not be a member of the elite Dow Jones Industrial Average. S&P Dow Jones Indices announced on Tuesday that the iconic maker of light bulbs and jet engines will be replaced in the 30-stock index by Walgreens Boots Alliance. GE (GE) was an original member of the…
Read MoreScammers Trick Seniors with ‘Free’ Medical Devices, Then Bill Medicare
Nancy DeLozier looked at the array of medical equipment on the floor of her living room and called it junk. The 84-year-old Northwest Side woman said she received the items in the mail but neither wants nor needs them. One shipment, from February 2017, included a back brace and knee braces. A second shipment, which…
Read MoreMIT’s 3D Printed Walking, Drug-Transporting Magnets
MIT engineers have created soft, 3-D-printed structures whose movements can be controlled with a wave of a magnet, much like marionettes without the strings. The menagerie of structures that can be magnetically manipulated includes a smooth ring that wrinkles up, a long tube that squeezes shut, a sheet that folds itself, and a spider-like “grabber”…
Read MoreDoctors Told Not to Order ECG’s for Low-Risk Patients
Doctors shouldn’t routinely perform electrocardiograms on patients at low risk for heart disease, an influential federal panel is recommending. While an ECG test of the heart’s electrical activity is safe and inexpensive, the benefits for patients at low risk of heart disease are very low and the results can trigger possibly dangerous, unnecessary follow-up testing…
Read MoreImplantable Device Delivers Drugs Straight to the Heart
An international team of researchers, led by Harvard University, have developed a refillable, implantable device, which sits directly on the heart and can deliver drugs and other therapies to treat the aftereffects of a heart attack. The device, dubbed Therepi, is a small patch that is sutured onto the heart. The patch contains a sponge-like…
Read MoreIntuitive Surgical Invests $15m Into Lung Cancer Startup
Intuitive Surgical has struck a deal with lung disease technology firm Broncus Medical. The multipart agreement includes a $15 million investment, technology development collaboration and a licensing deal. Broncus has built its business upon a portfolio of technology platforms that support the diagnosis of lung cancer and treatment of emphysema. These devices provide image guidance to help…
Read MorePositive Clinical Data for Penny-Sized Bioelectronic Implant
SetPoint Medical’s open-label study supports the use of the company’s bioelectronic therapy for Crohn’s Disease. The Valencia,CA-based company’s study was conducted at five European sites and included 16 patients with moderate to severe Crohn’s Disease with inadequate responses to tumor necrosis factor (TNF) antagonist drugs and other non-TNF targeted biologic agents. The data, presented…
Read MoreBoston Scientific Will Not Comment on Reported Stryker Takeover Offer
Boston Scientific said Monday it won’t comment on reports rival medical device manufacturer Stryker made a takeover bid, which was first reported by The Wall Street Journal. Stryker’s shares tumbled more than 4 percent, and Boston Scientific’s rose nearly 8 percent Monday in afternoon trading. They were halted before Boston released its statement. “Boston Scientific … is aware…
Read More